Clinical relevance of detectable HCV RNA in the context of direct acting antivirals.

Thumbnail Image
Files
KOS_ClinicalSV2012.pdf(186.63 KB)
Submitted Version
Date
2012-07-14
Authors
O'Sullivan, Kathleen
Levis, John
Hegarty, Kevin G.
Crosbie, Orla
Kenny-Walsh, Elizabeth
Fanning, Liam J.
Journal Title
Journal ISSN
Volume Title
Publisher
Wiley
Published Version
10.1002/hep.25942
Research Projects
Organizational Units
Journal Issue
Abstract
Description
Keywords
HCV , Hepacivirus , Hepatitis C, , Oligopeptides , RNA
Citation
O'Sullivan, K., Levis, J., Hegarty, K., Crosbie, O., Kenny-Walsh, E. and Fanning, L. J. (2013), Clinical relevance of detectable hepatitis C virus RNA in the context of direct-acting antivirals. Hepatology, 57, pp. 855–856. http://dx.doi.org/10.1002/hep.25942
URI
https://hdl.handle.net/10468/2759
Collections
Medicine - Journal Articles
Copyright
© 2012 by the American Association for the Study of Liver Diseases. This is the pre-peer reviewed version of the following article: O’Sullivan et al. (2013), Clinical relevance of detectable hepatitis C virus RNA in the context of direct-acting antivirals. Hepatology, 57: 855–856, which has been published in final form at doi:10.1002/hep.25942. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving.